TMLI: A better TBI or more of the same? Journal Article
| Author: | Giralt, S. |
| Article Title: | TMLI: A better TBI or more of the same? |
| Abstract: | Total body irradiation (TBI) has been an integral component of allogeneic hematopoietic stem cell transplantation since this treatment modality was pioneered by Dr E. Donald Thomas in the 1970s.1 Although higher TBI doses are associated with better disease control in patients with myeloid leukemias, the increased risk of TBI-related toxicities negate any potential survival advantage. |
| Keywords: | cancer chemotherapy; cancer survival; event free survival; overall survival; busulfan; fludarabine; allogeneic stem cell transplantation; note; cancer radiotherapy; radiation dose; mucosa inflammation; melphalan; whole body radiation; myeloid leukemia |
| Journal Title: | Blood |
| Volume: | 117 |
| Issue: | 1 |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2011-01-06 |
| Start Page: | 9 |
| Language: | English |
| DOI: | 10.1182/blood-2010-10-312132 |
| PROVIDER: | scopus |
| PUBMED: | 21212291 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 4 March 2011" - "CODEN: BLOOA" - "Source: Scopus" |
